Search Results
Oct 02, 2025, 08:58 ET APUS Honors Top Scholars for Academic Excellence
Brandon Gene Arroyo
More news about: American Public University System
Oct 02, 2025, 08:49 ET Akadeum Life Sciences to Provide Clinical & Tech Updates, Moderate Panel Alongside Industry Leaders at Cell & Gene Meeting on the Mesa
cell isolation microbubble technology at the annual Cell & Gene Meeting on the Mesa, taking place October 6–8, 2025, at the historic Arizona Biltmore Resort. Akadeum will also moderate a high-profile Science Slam
More news about: Akadeum Life Sciences
Oct 02, 2025, 08:08 ET Eisai Highlights Breadth of Oncology Research at ESMO 2025, Featuring 5-Year Survival Data from Study 309/KEYNOTE-775
/ β-catenin pathway-dependent gene expression. Since E7386 is thought to act on the CBP / β-catenin transcription complex located at the most downstream of the Wnt signaling, it is expected to inhibit not only ligand-dependent activation but also activation caused by gene mutations in Wnt signaling factors
More news about: Eisai Inc.
Oct 02, 2025, 06:36 ET ExQor Technologies Announces Advancement Toward Clinical Trials for Brain Regenerative Medicine Platform to Treat Alzheimer's Disease
those previously unable to reach therapeutic levels in the CNS—to become viable options for treatment of neurological conditions, brain cancers, and gene therapies. Market Impact and Patient Benefits For the approximately
More news about: ExQor Technologies Inc
Oct 01, 2025, 15:58 ET McNICHOLS CO. Builds on Family Legacy Through Partnership With One Equity Partners
customer-centric culture and preserving our core values and the Hole Team's desire to completely satisfy every customer we are blessed to serve. Our Chairman, Gene McNichols, who has been blessed to be part of the team for over 59 years, is grateful for our faithful customers and associates who helped build McNICHOLS
More news about: McNichols Company
Oct 01, 2025, 11:04 ET BioMarin apresenta novos dados que reforçam sua liderança em saúde óssea na reunião anual da Sociedade Americana de Pesquisa Óssea e Mineral
A acondroplasia, a forma mais comum de displasia esquelética, é caracterizada pelo crescimento ósseo prejudicado causado por uma mutação no gene FGFR3.2 O crescimento ósseo é regulado por vários processos biológicos, incluindo vias de sinalização através do fator de crescimento
More news about: BioMarin
Oct 01, 2025, 10:00 ET 9/11 Study Shows How Toxic Exposures May Lead to Blood Cancers
researchers found that younger first responders (those under age 60) with elevated CH possessed a set of gene mutations quite distinct from the classic mutations associated with age-related CH—indicating that the gene-altering toxins in WTC dust may contribute to cancer risk by accelerating the aging process.
More news about: Montefiore Einstein Comprehensive Cancer Center
Oct 01, 2025, 09:01 ET Laguna Diagnostics Awarded Second U.S. Patent for Rapid Blood Tests to Differentiate Schizophrenia and Bipolar Disorder, Expanding IP Portfolio in $3B Market
psychiatrically normal individuals (NC). The method comprises: a) Precision Biomarker Signatures determining the mRNA* gene expression level of 18 genes;b) proceeds in a four-step process;c) calculating the probability that a sample comes from a subject
More news about: Laguna Diagnostics, LLC
Oct 01, 2025, 09:00 ET Foundation Fighting Blindness Celebrates Blindness Awareness Month with #ShareYourVision Campaign
cures for inherited blinding diseases show unprecedented promise. The Foundation's research has already contributed to LUXTURNA®, the first FDA-approved gene therapy for an inherited eye disease, and more than 50 clinical trials currently underway globally. "Blindness isn't one experience—it's
More news about: Foundation Fighting Blindness
Oct 01, 2025, 08:30 ET Cryoport Systems Expands Global Footprint with New Global Supply Chain Center in Paris, France
temperature-sensitive commodities. The facility will be immediately operational, providing logistics support for biopharma, including cell and gene therapies, biologics, animal health and reproductive medicine. During the months following, the Paris GSCC will add BioServices, biostorage, QP drug
More news about: Cryoport, Inc.
Oct 01, 2025, 08:00 ET RheumaGen Announces Oral Presentation on HLA Gene-Editing Preclinical Data for Lead Autoimmune Disease Program at ACR Convergence 2025
Oct. 1, 2025 /PRNewswire/ -- RheumaGen, Inc., a cell and gene therapy company engineering a new class of therapeutics for major autoimmune diseases, today announced that a human leukocyte antigen (HLA) gene-editing abstract has been selected for oral presentation at the American College
More news about: RheumaGen, Inc.
Oct 01, 2025, 08:00 ET Sentynl Therapeutics updates on its NDA for CUTX-101
About Menkes Disease Menkes disease is a rare X-linked recessive pediatric disease caused by gene mutations of the copper transporter ATP7A. The minimum birth prevalence for Menkes disease is believed to be 1 in 34,810 live male births, and potentially
More news about: Sentynl Therapeutics
Oct 01, 2025, 06:55 ET Corteva Announces Plan to Separate into Two Industry-Leading Public Companies
will include targeted M&A, sustained investment in R&D and the fulfillment of existing opportunities: out-licensing, hybrid wheat, biofuels and gene editing. By consistently delivering value to farmers and shareholders alike, SpinCo will deliver its next phase of innovation-driven
More news about: Corteva, Inc.
Oct 01, 2025, 06:30 ET PROSPERITY BANCSHARES, INC.® TO ACQUIRE SOUTHWEST BANCSHARES, INC. IN SAN ANTONIO, TEXAS
In addition, upon completion of the merger, Gene Dawson, Jr., Interim Chairman, President and Chief Executive Officer of Southwest, will join the Board of Directors of Prosperity Bank. "It has been a pleasure getting to know Gene, Brent, Tom and the management team at Southwest.
More news about: Prosperity Bancshares, Inc.
Oct 01, 2025, 06:03 ET Karmanos Thinks Pink, Recognizes Breast Cancer Awareness Month in October
of male breast cancer are estimated in the U.S. in 2025. Approximately 5%-10% of breast cancers can be linked to inherited gene mutations. All data reported by the American Cancer Society.
More news about: Karmanos Cancer Institute
Sep 30, 2025, 21:50 ET GROUNDBREAKERS 2025: Prologis CEO, Secretary Burgum Headline Forum Focusing on Energy Reliability, AI and the Future of Global Supply Chains
The customer is changing every quarter," said Jane. 2028 Summer Olympic Games: Gene Sykes (U.S. Olympic & Paralympic Committee) and Matt Wikstrom (U.S. Olympic and Paralympic Properties) joined Will O'Donnell (Prologis)
More news about: Prologis, Inc.
Sep 30, 2025, 14:09 ET CeraVe 與 L'Oréal Groupe 憑藉突破性頭皮屑研究榮獲 IFSCC Applied Research Award
L'Oréal 的 CeraVe 醫療事務及傳訊全球高級副總裁 Gene Colón表示：「我們獲頒 IFSCC Applied Research，證明我們共同履行科學創新與探討皮膚和頭皮屏障健康複雜生物學的承諾。這項變革研究超越傳統頭皮屑觀點，並強調神經酰胺缺乏和頭皮屏障功能障礙、關鍵細菌成份與種族的影響。它大幅擴展我們根植於基礎神經酰胺科學的科學理解，並為未來創新提供全新視角和可能。」
More news about: CeraVe
Sep 30, 2025, 13:54 ET Emily Whitehead Foundation Expands Mission Beyond Pediatric Cancer: Supporting All Individuals with Cancer and Rare Diseases
revolutionary CAR T-cell therapy that saved Emily's life," said Tom Whitehead, co-founder of the Emily Whitehead Foundation. "As the field of cell and gene therapies has rapidly advanced, we've seen the incredible potential of these innovative treatments to transform lives across a wider spectrum of diseases.
More news about: Emily Whitehead Foundation
Sep 30, 2025, 11:45 ET Made Scientific and Syenex Forge Technology Partnership to Transform T Cell Therapy Manufacturing
and efficiency of engineered T cell therapies through the use of Syenex's bioengineering systems, UltraCell™ and RapidCell™, providing improvement in gene delivery efficiency and engineering timelines.
More news about: Made Scientific, Inc.
Sep 30, 2025, 11:34 ET CeraVe y L'Oréal Groupe ganan el prestigioso Premio de Investigación Aplicada de IFSCC
conjunto con la innovación científica y la comprensión de la compleja biología de la salud de la barrera cutánea y del cuero cabelludo", afirmó Gene Colón, vicepresidente sénior global de Asuntos Médicos y Comunicaciones de CeraVe en L'Oréal. "Esta investigación revolucionaria trasciende la
More news about: CeraVe
Sep 30, 2025, 10:59 ET CeraVe e L'Oréal Groupe ganham o prestigioso IFSCC Applied Research Award pelo Breakthrough Dandruff Study
compromisso conjunto com a inovação científica e a compreensão da intrincada biologia da saúde da barreira da pele e do couro cabeludo", disse Gene Colón, Vice-Presidente Sênior Global de Assuntos Médicos e Comunicações da CeraVe na L'Oréal. "Esta pesquisa revolucionária vai além da visão
More news about: CeraVe
Sep 30, 2025, 10:43 ET CeraVe y L'Oréal Groupe ganan el prestigioso premio IFSCC Applied Research Award por su innovador estudio sobre la caspa
conjunto con la innovación científica y la comprensión de la intrincada biología de la salud de la barrera de la piel y el cuero cabelludo", dijo Gene Colón, Vicepresidente Senior Global de CeraVe en L'Oréal. "Esta investigación revolucionaria va más allá de la visión tradicional de la caspa
More news about: CeraVe
Sep 30, 2025, 10:27 ET CeraVe und L'Oréal Groupe gewinnen prestigeträchtigen IFSCC-Preis für angewandte Forschung für bahnbrechende Schuppenstudie
unser gemeinsames Engagement für wissenschaftliche Innovation und das Verständnis der komplexen Biologie der Haut- und Kopfhautbarriere", sagte Gene Colón, Global Senior Vice President, Medical Affairs & Communications für CeraVe bei L'Oréal. „Diese bahnbrechende Forschungsarbeit geht
More news about: CeraVe
Sep 30, 2025, 08:34 ET Gene Juarez Expands Beyond Western Washington with Spokane Opening
About Gene Juarez Salons & Spas: Gene Juarez is a trusted leader in beauty and wellness, offering elevated salon and spa services that blend artistry with modern innovation. Established in 1971 by visionary stylist Gene Juarez, the brand began with a mission to
More news about: Gene Juarez
Sep 30, 2025, 08:34 ET Epigenica AB Launches the Groundbreaking EpiFinder™ GenomePro - Unlocking the Epigenome with Unprecedented High Throughput and Multiplexing Features
ChIP-seq data - without significant time investment," says Björn Reinius, Associate Professor at the Karolinska Institute with a research focus on gene dosage compensation. "With minimal optimization, the protocol enables users to generate quantitative ChIP-seq libraries and to perform preliminary
More news about: Epigenica AB